Ironwood Pharmaceuticals Inc (IRWD)
8.115
0.00 (0.00%)
USD |
NASDAQ |
May 06, 16:00
8.115
0.00 (0.00%)
After-Hours: 18:08
Ironwood Pharmaceuticals Cash from Financing (Quarterly): -50.90M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -50.90M |
| September 30, 2023 | -74.99M |
| June 30, 2023 | 399.07M |
| March 31, 2023 | 3.981M |
| December 31, 2022 | 2.806M |
| September 30, 2022 | 0.797M |
| June 30, 2022 | -150.28M |
| March 31, 2022 | -90.87M |
| December 31, 2021 | -18.59M |
| September 30, 2021 | 6.164M |
| June 30, 2021 | 5.662M |
| March 31, 2021 | 2.211M |
| December 31, 2020 | 3.524M |
| September 30, 2020 | 0.67M |
| June 30, 2020 | 2.397M |
| March 31, 2020 | 11.96M |
| December 31, 2019 | 6.447M |
| September 30, 2019 | 8.633M |
| June 30, 2019 | -7.50M |
| March 31, 2019 | -8.765M |
| December 31, 2018 | 4.849M |
| September 30, 2018 | 7.81M |
| June 30, 2018 | 12.13M |
| March 31, 2018 | 5.285M |
| December 31, 2017 | 6.163M |
| Date | Value |
|---|---|
| September 30, 2017 | -14.91M |
| June 30, 2017 | 9.479M |
| March 31, 2017 | 19.10M |
| December 31, 2016 | 5.177M |
| September 30, 2016 | -3.389M |
| June 30, 2016 | -2.094M |
| March 31, 2016 | -3.87M |
| December 31, 2015 | -2.344M |
| September 30, 2015 | -3.975M |
| June 30, 2015 | 303.97M |
| March 31, 2015 | 5.418M |
| December 31, 2014 | 7.501M |
| September 30, 2014 | 2.475M |
| June 30, 2014 | 6.963M |
| March 31, 2014 | 194.00M |
| December 31, 2013 | 1.195M |
| September 30, 2013 | 0.967M |
| June 30, 2013 | 141.12M |
| March 31, 2013 | 170.30M |
| December 31, 2012 | 1.067M |
| September 30, 2012 | 0.469M |
| June 30, 2012 | 1.333M |
| March 31, 2012 | 86.10M |
| December 31, 2011 | 0.62M |
| September 30, 2011 | 0.565M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-150.28M
Minimum
Jun 2022
399.07M
Maximum
Jun 2023
3.220M
Average
2.397M
Median
Jun 2020
Cash from Financing (Quarterly) Benchmarks
| Societal CDMO Inc (DELISTED) | -0.854M |
| Mirum Pharmaceuticals Inc | 1.777M |
| Tharimmune Inc | 9.662M |
| Kineta Inc | 2.246M |
| Moderna Inc | 14.00M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 35.83M |
| Cash from Investing (Quarterly) | -4.188M |
| Free Cash Flow | 183.15M |
| Free Cash Flow Per Share (Quarterly) | 0.2283 |
| Free Cash Flow to Equity (Quarterly) | 60.22M |
| Free Cash Flow to Firm (Quarterly) | 35.21M |
| Free Cash Flow Yield | 13.18% |